Unilabs SA Announces First-Year Status on CE Marked STRATIFY JCV® ELISA Testing
3/21/2012 7:27:35 AM
COPENHAGEN, Denmark--(BUSINESS WIRE)--Unilabs today announced the one-year status on testing in Europe and several other markets outside Europe with the CE marked ELISA test STRATIFY JCV®. STRATIFY JCV is an important tool used to help enable individual benefit-risk assessment for patients with multiple sclerosis (MS) by identifying their anti-JC virus (JCV) antibody status. In 2011, Unilabs was selected by Biogen Idec and Elan Corporation, plc to provide STRATIFY JCV testing services for the detection of anti-JCV antibodies.
comments powered by